The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study.


Journal

Clinical oncology (Royal College of Radiologists (Great Britain))
ISSN: 1433-2981
Titre abrégé: Clin Oncol (R Coll Radiol)
Pays: England
ID NLM: 9002902

Informations de publication

Date de publication:
04 2021
Historique:
received: 28 08 2019
revised: 14 09 2020
accepted: 06 11 2020
pubmed: 1 12 2020
medline: 25 2 2023
entrez: 30 11 2020
Statut: ppublish

Résumé

Childhood cancer survival is suboptimal in most low- and middle-income countries (LMICs). Radiotherapy plays a significant role in the standard care of many patients. To assess the current status of paediatric radiotherapy, the International Atomic Energy Agency (IAEA) undertook a global survey and a review of practice in eight leading treatment centres in middle-income countries (MICs) under Coordinated Research Project E3.30.31; 'Paediatric radiation oncology practice in low and middle income countries: a patterns-of-care study by the International Atomic Energy Agency.' A survey of paediatric radiotherapy practices was distributed to 189 centres worldwide. Eight leading radiotherapy centres in MICs treating a significant number of children were selected and developed a database of individual patients treated in their centres comprising 46 variables related to radiotherapy technique. Data were received from 134 radiotherapy centres in 42 countries. The percentage of children treated with curative intent fell sequentially from high-income countries (HICs; 82%) to low-income countries (53%). Increasing deficiencies were identified in diagnostic imaging, radiation staff numbers, radiotherapy technology and supportive care. More than 92.3% of centres in HICs practice multidisciplinary tumour board decision making, whereas only 65.5% of centres in LMICs use this process. Clinical guidelines were used in most centres. Practice in the eight specialist centres in MICs approximated more closely to that in HICs, but only 52% of patients were treated according to national/international protocols whereas institution-based protocols were used in 41%. Quality levels in paediatric radiotherapy differ among countries but also between centres within countries. In many LMICs, resources are scarce, coordination with paediatric oncology is poor or non-existent and access to supportive care is limited. Multidisciplinary treatment planning enhances care and development may represent an area where external partners can help. Commitment to the use of protocols is evident, but current international guidelines may lack relevance; the development of resources that reflect the capacity and needs of LMICs is required. In some LMICs, there are already leading centres experienced in paediatric radiotherapy where patient care approximates to that in HICs. These centres have the potential to drive improvements in service, training, mentorship and research in their regions and ultimately to improve the care and outcomes for paediatric cancer patients.

Identifiants

pubmed: 33250288
pii: S0936-6555(20)30418-0
doi: 10.1016/j.clon.2020.11.004
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e211-e220

Informations de copyright

Copyright © 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Auteurs

Y Anacak (Y)

Ege University School of Medicine, Izmir, Turkey.

E Zubizarreta (E)

International Atomic Energy Agency, Vienna, Austria.

M Zaghloul (M)

National Cancer Institute, Cairo University, Cairo, Egypt; Children's Cancer Hospital, Cairo, Egypt.

S Laskar (S)

Tata Memorial Hospital, Mumbai, India.

J Alert (J)

Instituto de Oncología y Radiobiología, Habana, Cuba.

S Gondhowiardjo (S)

Faculty of Medicine, University of Indonesia/Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.

A Giselvania (A)

Faculty of Medicine, University of Indonesia/Dr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.

R Correa-Villar (R)

Centro Infantil Boldrini, Sao Paulo, Brazil.

F Pedrosa (F)

Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil.

B Dorj (B)

National Cancer Centre, Ulaanbaatar, Mongolia.

S Kamer (S)

Ege University School of Medicine, Izmir, Turkey.

S C Howard (SC)

University of Tennessee Health Science Center, Memphis, TN, USA.

Y Quintana (Y)

Harvard Medical School, Boston, MA, USA.

R C Ribeiro (RC)

St Jude Children's Research Hospital, Memphis, TN, USA.

E Rosenblatt (E)

International Atomic Energy Agency, Vienna, Austria.

K Hopkins (K)

International Atomic Energy Agency, Vienna, Austria. Electronic address: k.i.hopkins@iaea.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH